MLAS Logo

Discover Our Expert Community

Dr Anthony Hammond

Consultant in Rheumatology and Pain Management MD, FRCP
Specialisms
Pain Management Rheumatology
Capabilities
Claimants & DefendantsHome AppointmentsRemote AppointmentsFace to FaceDesktop ReportsNHS ContractedLegal Aid (LLA)Report Turnaround: 4 - 6 weeksClaimant Age: 18+

Practice Locations

3 locations available for appointments

3

Click a venue to view on the map

Litfield House

Bristol, BS8 3LS

DRG Health Clinic

Doncaster, DN1 1BL

Fortius Clinic

London, W1U 2SB

Medico-Legal Experience

Dr Tony Hammond is a Consultant Rheumatologist with extensive medico-legal experience, having acted as an expert witness since 2016. He holds the Cardiff University Bond Solon Expert Witness Certificate, demonstrating his commitment to the highest standards of expert reporting and court testimony.

He is regularly instructed in both personal injury and clinical negligence matters and accepts instructions from both claimants and defendants. Dr Hammond is happy to opine on breach of duty, causation, liability, and condition and prognosis.

Throughout his time as an expert witness, he has covered the full breadth of Rheumatology, completing reports on fibromyalgia, Lupus, and industrial injury such as tendonitis. He has particular specialist knowledge of the interventional management of spine and joint pain.

Dr Hammond has built a reputation for his detailed approach to his reports, and he combines his ongoing clinical practice with his medico-legal work, ensuring his opinions are grounded in current, real-world clinical expertise.

Dr Hammond has appeared in Court on multiple occasions and is well-versed in giving oral evidence.

Dr Hammond has extensive experience with cases associated with:

Personal injury and clinical negligence relating to:

  • Lupus:
    • Systemic lupus erythematosus (SLE)
    • Cutaneous lupus erythematosus (CLE)
    • Discoid Lupus Erythematosus (DLE)
  • Arthritis:
    • Rheumatoid arthritis (RA)
    • Reactive arthritis
    • Psoriatic arthritis (PsA)
    • Osteoarthritis
    • Polymyalgia rheumatica (PMR)
    • Gout
  • Chronic pain:
    • Complex Regional Pain Syndrome (CRPS)
    • Fibromyalgia (FMS)
    • Facet pain
    • Chronic widespread pain (CWP)
    • Chronic neuropathic pain
    • Myofascial pain
    • Back and neck pain
    • Disc-related spinal pain
    • Lumbar, cervical, and thoracic spinal pain
    • Sciatica
    • Discogenic pain
  • Inflammatory spinal conditions:
    • Axial Spondyloarthritis (axSpA)
    • Ankylosing spondylitis (AS)
    • Inflammatory sacroiliitis
  • RTA-related conditions:
    • Musculoskeletal pain
    • Soft tissue injury
    • Restricted movement
  • Sports injuries:
    • Shin splints
    • Tennis elbow
    • Knee injury
    • Ankle sprains
    • Groin pulls
    • Musculoskeletal (MSK) pain
    • Hamstring strains
  • Autoimmune conditions:
    • Scleroderma
    • System sclerosis
    • Behcet’s Syndrome (or disease)
    • Giant Cell Arteritis (GCA)
    • Churg-Strauss Syndrome/Eosinophilic Granulomatosis with Polyangiitis (EGPA)
    • Antiphospholipid Syndrome (APS)
    • Immunoglobulin G4-Related Disease (IgG4-RD)
  • Industrial injury:
    • Repetitive strain injury (RSI)
    • Carpal tunnel syndrome (CTS)
    • Tendonitis
    • Vibration white finger (VWF)
  • Missed/incorrect diagnosis of rheumatological conditions
  • Delayed referral
  • Failure to monitor rheumatological conditions
  • Inflammatory fibrosis (Storiform)
  • Vasculitis
  • Ehlers-Danlos syndrome (EDS)
  • Hypermobility Spectrum Disorder (HSD)
  • Morton’s neuroma
  • Gait analysis
  • Spinal stiffness
  • Sensory complaints
  • Nerve root blocks
  • Knee denervation
  • Hip denervation
  • Shoulder denervation
  • Delayed diagnosis of Osteoporosis
  • Degenerative joint disease
  • Swelling of the joints
  • Small fibre neuropathy
  • Vitamin D deficiency
  • Lyme disease
  • Osteopenia
  • Raynaud’s

Dr Hammond’s appointment availability is 2-4 weeks and has a report turnaround time of 4-6 weeks. 

Clinical Experience

Dr Hammond is a highly experienced Consultant Physician and Rheumatologist with over 30 years of expertise in internal medicine, rheumatology, and interventional pain management. He graduated from the University of Edinburgh Medical School in 1980 and undertook postgraduate training in Internal Medicine and Rheumatology in Bristol, Bath, and at St Bart’s Hospital in London.

He completed an MD in the Immunopathology of Systemic Lupus Erythematosus under the supervision of Professor Sir Mark Walport at Hammersmith Hospital, contributing to the understanding of autoimmune disease mechanisms.

In 1992, Dr Hammond was appointed Consultant Physician and Rheumatologist at Maidstone Hospital. Over the next 18 years, he led and expanded the department from a single consultant service to a team of three, establishing a strong research culture. During his tenure, he employed two research nurses, conducted 30 clinical research projects, and published nearly 50 peer-reviewed papers.

In 2010, Dr Hammond left Maidstone and Tunbridge Wells NHS Trust to help establish the Kent Institute of Medicine and Surgery (KIMS). He played a central leadership role and served as Clinical Chairman from 2013 to 2016, overseeing clinical strategy and development.

Dr Hammond currently practices full-time in Rheumatology and Interventional Pain Management. He works three days per week as a Locum Consultant Rheumatologist and dedicates one day weekly to Pain Management at Croydon University Hospital.

Frequently Asked Questions

Can Dr Hammond comment on EDS/hypermobility?

Yes, Dr Hammond can take this.

Can Dr Hammond comment on pre-existing polymyalgia rheumatica?

Yes, he can assist with this.

Can Dr Hammond comment on soft tissue injuries?

No, this is not something he can assist with at the moment.

Can Dr Hammond report on a case involving delayed referral/diagnosis of Osteoporosis?

Yes, he can assist with this.

Can you comment on Lyme Disease, Neck Pathology and Reactive Arthritis?

Yes, Dr Hammond can assist with this.

Can you assist with a case where the claimant has pre existing Raynaud’s disease?

Yes, he can assist with this.

Publications

  • EQ 5-D As a suitable assessment of quality of life after epiduroscopy. Multicentre randomised double-blinded pilot study. Griger, Metal (in preparation)
  • Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: Single agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate Chandrupatla DMSH, Molthoff CFM, Ritesma IGR, Vos, R, Elsof E, Matsutama T, Low PS, Musters RJP, Hammond A, Windhorst AD, Lamertsma AA, van der Laken CJ, Braands R, Jansen G
  • Access to the Next Wave of Biologic Therapies (Abatacept and Tocilizumab) for the Treatment of Rheumatoid Arthritis in England and Wales: Addressing Difficulties with the Current NICE Guidance (MTA195 and TA198). Yee Chiu, Andrew Ostor, Anthony Hammond, Katharina Sokoll, Marina Anderson, Maya Buch, Michael R Ehrenstein, Patrick Gordon, Sophia Steer, Ian N Bruce. Submitted. Clinical rheumatology, PMID: 22271229
  • Rheumatoid Arthritis Patients with Inadequate Response to Oral Methotrexate Maintain Satisfactory Disease Control and Durable Long-term Response when Switched to Subcutaneous. Hammond A , Bately B. Eular 2014 poster
  • Hylastan versus steroid for knee osteoarthritis: Double-blind randomised trial. Lawrence Housman MD1, Nebojsa Skrepnik MD, PhD1, Nathan Wei MD, FACP, FACR2, Thomas J Schnitzer MD, PhD3, David Waddell MD4, Charles Birbara MD5, Hasan Tahir BSc, MBBS, FRCP6, Nigel Arden MBBS, FRCP, MSc, MD7, Anthony Hammond MD, FRCP8, Phillippe Goupille MD9, Bernd-Jan Sanson MD, PhD10, Francois Bailleul MD10, Clare Elkins MS11, Thierry Conrozier MD. Knee Surgery Sports Traumatology Arthroscopy. Published online 15th Feb 2013. DOI 10.1007/s00167-013-2438-7
  • Subcutaneous Methotrexate is More Efficacious and Better Tolerated Than Oral Methotrexate: The Experience of a Large Group of Patients in the Rheumatology Department of a District General Hospital A. Liakos, M. Batley , T. Hammond, A. Saha , P. Shrestha, A. Keough. Ann Rheum Dis 2012;71 (Suppl3):67
  • The Impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis. Campbell RCJ, Bately M, Hammond A, Ibrahim F, Kingsley G, Scott D. In submission 2011, Clinical Rheumatology
  • Use of Parenteral Methotrexate significantly reduces the need for biologic therapy Rheumatology 2007: 46 (1):i25
  • Strict adherence to BASDAI score may mislead the treatment decisions in patients with Ankylosing spondylitis. Arthritis Rheum September 2007, Volume 56
  • Abatacept (ABA) provides sustained clinical benefit through three years in Rheumatoid Arthritis (RA) in patients (PTs) with inadequate responses to Methotrexate (MTX). Hammond A, Emery P, Aranda R, Becker J P, Zhou Y, Dougados M and Westhovens R. BSR 2007 Final abstract number: 53
  • Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond A and Brazier J. 2007 Arthritis Care and research (manuscript ref ACR-06-0117) NB provenance of final publication uncertain
  • Bansback N, Brennan A, Reynolds A, Conway P and Hammond T. 2001 In Rheumatoid arthritis (RA) Utility should be Calculated from EQ-5D Rather that SF-36 due to Floor Effects. Arthritis and Rheumatism, (S) abstract 209 ACR 2001
  • Hammond A and Jeganathan N. 2001. Experience of anti-TNF treatment with Infliximab (Remicade) and Methotrexate in routine clinical practice over 40 weeks. Rheumatology 40: 149 (S1) DIO: 10.1056/NEJM200011303432202
  • Peterson PL, Steer S, DeLord D, and Hammond A. 2001. Treatment of refractory orbital myositis with Infliximab (Remicade) a case report. Rheumatology 40: 346 (S1)
  • Monaghan J, Hammond A, Rodway A, Conry B and MacFarlane D. 2001. Identifying Patients at risk of Osteoporosis in General Practice. Osteoporosis International 12: S40 (S1)
  • Steer S, Monaghan J and Hammond A. 1999. Maidstone Osteoporosis Case Ascertainment Study: Discovering Unmet Need. 1999. Annals Rheum Diseases. 242. (S)
  • Donnelly, S., J.T. Bourne, D.A. Levinson, D.V.Doyle, and A Hammond. 1993. Grand Rounds in Rheumatology: Amyloid arthritis associated with IgM kappa lymphoplamacytoid lymphoma. British Journal of Rheumatology. 32: 1004 –1007
  • Spector TD. Woodward L. Hall GM. Hammond A. Williams A. Butler MG. James IT. Hart DJ Thompson PW. Scott DL. 1992. Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases. Annals of the Rheumatic Diseases.51(10):1134-7
  • Hammond. A, W. Ollier, and MJ. Walport. 1992. Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B. Clin. Exp. Immunol. 88:163-8
  • Hammond. A, AC. Rudge, S. Loizou, SJ. Bowcock, and MJ. Walport. 1989. Reduced numbers of CR1 on erythrocytes from patients with SLE and the antiphospholipid syndrome are associated with increased levels of anticardiolipin antibodies. Arthritis and Rheumatism. 32: 259-264
  • Walport, M.J., Hammond .A, Davies, K.A.A., Moldenuaer, F. 1989. Complement receptor type-1 and SLE. In: Proceedings of the Second International Conference on SLE. Professional Postgraduate Services, Tokyo, 52-55
  • Hammond A, Loizou S, Cofiner C, Walport MJ. 1990. Anticardiolipin antibodies (ACA) may be a common anti-erythrocyte autoantibody. Clinical and Experimental Rheumatology. 8: 32B (S)
  • Hammond A and Walport MJ. 1988. C4A and C4B deposition on red cells from patients with SLE and normal controls. British Journal of Rheumatology. 27:2 40 (S)
  • Hammond A and Doyle DV. 1992. Computers in medical audit: Experience with the NE Thames Clinical Information System (CIS). British Journal of Rheumatology. 31:2 146 (S)
  • Woodward L, Spector TD, Hammond A, Hall GM, Williams A, Doyle DV, Scott D.L. 1991 Keratan Sulphate and the acute phase response. British Journal of Rheumatology.30:2 236 (S)
  • Doyle DV and Hammond A. 1990. Rheumatology Clinical Referral Audit and General Practitioner Education Planning. British Journal of Rheumatology. 29:2 169 (S)
  • Johnston, SRD, A. Hammond, L. Griffiths, R. Greenwood, and CRA. Clarke. 1989. Subarachnoid haemorrhage – Can we do better? Journal of the Royal Society of Medicine. 82:721-724
  • Pozniak, A, and A. Hammond. 1983. A report on the use of trans-oesophageal pacing in a case of hypothermia. Brit Med J. 289: 1315

Request a Redacted Report

To gain access to a redacted report from this expert, please leave your details below and a member of the team will issue this to you.

Instruct This Expert

To instruct this expert, please leave your details below and a member of the team will be in touch to discuss your requirements.

Copyright 2026 MLAS - All Rights Reserved.
Terms & Conditions - Sitemap - Modern Slavery Statement

MLAS
Privacy Overview

Medical & Legal Admin Services Limited (MLAS) understands that your privacy is important to you and that you care about how your personal data is used and shared online. We respect and value the privacy of everyone who visits this website, www.mlas.co.uk (“Our Site”) and will only collect and use personal data in ways that are described here, and in a manner that is consistent with Our obligations and your rights under the law.